GSK drops out of $20B race for Pfiz­er's con­sumer health unit — shares surge

Glax­o­SmithK­line has de­cid­ed not to pur­sue an ac­qui­si­tion of Pfiz­er’s con­sumer health busi­ness af­ter all, rais­ing ques­tions as to what they might spend on in­stead …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER